JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 18, 2007; DOI: 10.1124/jpet.107.125732


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.125732v1
323/3/805    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McPherson, C. S.
Right arrow Articles by Lawrence, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McPherson, C. S.
Right arrow Articles by Lawrence, A.


Received for publication May 15, 2007.
Revised September 15, 2007.
Accepted for publication September 17, 2007.

QUANTIFICATION OF pCREB EXPRESSION THROUGHOUT THE BRAIN OF AMPHETAMINE SENSITIZED RATS: ACTIVATION OF HYPOTHALAMIC OREXIN A-CONTAINING NEURONS

Cameron Scott McPherson 1, Travis Featherby 1, Elena Krstew 1, Andrew Lawrence 1*

1 Howard Florey Institute

* Address correspondence to: E-mail: andrew.lawrence{at}hfi.unimelb.edu.au

Abstract

In the present study using rats, we have examined acute, contextual and sensitized patterns of activated or phosphorylated CREB (pCREB) expression in parallel, assaying across multiple nuclei which have been implicated in addiction. The paradigm employed included a comparison of pre-treatment dose of amphetamine upon patterns of cellular activation, following re-challenge. As efferent orexinergic projections synapse on many targets through the mammalian brain, including mesotelencephalic regions and limbic systems involved in drug reward and reinforcement, we examined for co-expression of pCREB or c-Fos double-labelling within orexin A-immunopositive neurons following sensitization. Acute challenge with amphetamine (1.5 mg/kg, i.p.) resulted in an increase in the number of pCREB-immunoreactive (-IR) cells within the substantia nigra but a decrease of pCREB-IR cells in the central and medial subnuclei of the amygdala. Contextual re-exposure to the drug treatment environment altered pCREB expression, particularly in the basal ganglia and hypothalamus, although these effects were dictated by pre-treatment dose of amphetamine. Sensitization to amphetamine resulted in robust increases in pCREB-IR cell numbers in the basal ganglia and lateral septum of rats that had been pre-treated with high dose (10 mg/kg, i.p.) but not low dose (2 mg/kg, i.p.) amphetamine, despite a similar behavioral response. Orexin A-containing cells in the hypothalamus of sensitized rats did not co-express pCREB; however, these cells double-labelled for c-Fos and orexin A. These data suggest that orexinergic neurons are activated during the expression of behavioral sensitization, although in a heterogenous manner with regards to afferent topologies and functional roles in the nervous system.


Key words: Amphetamine, c-Fos, immunohistochemistry, orexin, pCREB, sensitization





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.